Picture of Er Therapeutics logo

PNGM Er Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro Cap

Annual balance sheet for Er Therapeutics, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

2006
November 30th
2007
November 30th
C2008
November 30th
C2009
November 30th
2010
November 30th
Period Length:
Source:10KSB10KSB10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Short Term Investments
Cash and Short Term Investments0.0960.0040.030.0040
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.1040.0040.030.0040
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.0060.0080.0010.440.413
Long Term Investments
Other Long Term Assets
Total Assets0.110.0120.1410.4540.424
Accounts Payable
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities0.0010.0110.20.3750.536
Total Long Term Debt
Total Debt
Total Liabilities0.0010.0110.20.3750.536
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity0.1090-0.0590.079-0.112
Total Liabilities & Shareholders' Equity0.110.0110.1410.4540.424
Total Common Shares Outstanding